Target Name: LST1
NCBI ID: G7940
Review Report on LST1 Target / Biomarker Content of Review Report on LST1 Target / Biomarker
LST1
Other Name(s): Leukocyte-specific transcript 1 protein | lymphocyte antigen 117 | B144 | leukocyte specific transcript 1 | Leukocyte specific transcript 1, transcript variant 4 | LST1 variant 4 | LST-1 | Lymphocyte antigen 117 | Protein B144 | Leukocyte-specific transcript 1 protein (isoform 4) | LST1_HUMAN | D6S49E

Understanding The Role of LST1 in Disease

LST1 (Leukocyte-specific transcript 1) is a gene that has been identified as a potential drug target or biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. LST1 is a protein that is expressed in a variety of cell types in the body, including white blood cells, neurons, and glial cells. It is known for its role in the immune response and has been implicated in the development and progression of several diseases.

One of the key functions of LST1 is its role in the immune response. LST1 is a member of the immunoglobulin superfamily and is involved in the development of antibodies, which are proteins that are capable of recognizing and neutralizing foreign substances in the body. LST1 is also involved in the regulation of T cell development and function, which are important for immune response and disease.

In addition to its role in the immune response, LST1 is also known for its role in the regulation of cell signaling pathways. LST1 has been shown to be involved in a number of signaling pathways that are important for cell growth, differentiation, and survival. For example, LST1 has been shown to be involved in the regulation of theNotch signaling pathway, which is involved in the regulation of cell proliferation and survival.

LST1 is also known for its role in the development and progression of several diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. For example, LST1 has been shown to be involved in the development of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease. LST1 may also be involved in the development of certain autoimmune disorders, such as rheumatoid arthritis and multiple sclerosis.

Despite these promising findings, much more research is needed to fully understand the role of LST1 in disease. LST1 is an attractive target for drug development due to its involvement in several important signaling pathways and its role in the development and progression of several diseases. Further research is needed to determine the full extent of LST1's involvement in disease and to develop effective treatments based on this understanding.

Protein Name: Leukocyte Specific Transcript 1

Functions: Possible role in modulating immune responses. Induces morphological changes including production of filopodia and microspikes when overexpressed in a variety of cell types and may be involved in dendritic cell maturation. Isoform 1 and isoform 2 have an inhibitory effect on lymphocyte proliferation

The "LST1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LST1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LTA | LTA4H | LTB | LTB4R | LTB4R2 | LTBP1 | LTBP2 | LTBP3 | LTBP4 | LTBR | LTC4S | LTF | LTK | LTN1 | LTO1 | LTV1 | LUADT1 | LUC7L | LUC7L2 | LUC7L3 | LUCAT1 | LUM | LUNAR1 | LURAP1 | LURAP1L | LURAP1L-AS1 | Luteinizing hormone | LUZP1 | LUZP2 | LUZP4 | LUZP6 | LVRN | LXN | LY6D | LY6E | LY6E-DT | LY6G5B | LY6G5C | LY6G6C | LY6G6D | LY6G6E | LY6G6F | LY6H | LY6K | LY75 | LY75-CD302 | LY86 | LY86-AS1 | LY9 | LY96 | LYAR | LYG1 | LYG2 | LYL1 | Lymphocyte antigen 6 complex | LYN | LYNX1 | LYPD1 | LYPD2 | LYPD3 | LYPD4 | LYPD5 | LYPD6 | LYPD6B | LYPD8 | LYPLA1 | LYPLA2 | LYPLA2P1 | LYPLA2P2 | LYPLAL1 | LYPLAL1-AS1 | LYRM1 | LYRM2 | LYRM4 | LYRM4-AS1 | LYRM7 | LYRM9 | LYSET | Lysine-Specific Demethylase 3 | Lysine-specific demethylase 5 | LYSMD1 | LYSMD2 | LYSMD3 | LYSMD4 | Lysophospholipid (edg) Receptors | LYST | Lysyl Oxidase Homolog | LYVE1 | LYZ | LYZL1 | LYZL2 | LYZL4 | LYZL6 | LZIC | LZTFL1 | LZTR1 | LZTS1 | LZTS1-AS1 | LZTS2 | LZTS3